NEO

#1894
NeoGenomics, Inc. - Common Stock
10.5 2 USD
+3.14%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
10.52
10.52
Year Range
4.72
13.74
Daily Change
+3.14%
Monthly Change
+16.11%
6 month change
-12.33%
Year Change
+42.93%
Previous Close
10.2 0
Open
10.5 2
Low
10.5 2
High
10.5 2
Volume
154
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 1.37 B
  • Employee 2 500
  • Founded 2002
  • CEO Christopher M. Smith
  • Website www.neogenomics.com
  • Headquarter Nevada, United States
  • FIGI BBG000BKH263
  • Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-13.95
Price to sales ratio
2.07

NeoGenomics, Inc. - Common Stock

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

News